Compare 10X Genomics Inc (TXG) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Zimmer Biomet Holdings Inc — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 3.2× 10X Genomics Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.07% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | ZBH | |
|---|---|---|
Market Cap | $5.48B | $17.36B |
Sector | Health | Health |
52-Week High | $45.80 | $107.71 |
52-Week Low | $11.34 | $79.58 |
Enterprise Value | $5.02B | $24.40B |
Dividend Yield | — | 1.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
